相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intraocular pressure (IOP) after intravitreal dexamethasone implant (Ozurdex) amongst different geographic populations-GEODEX-IOP study
Ashish Sharma et al.
EYE (2020)
Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study
HyunJeong Cho et al.
BMJ OPEN (2019)
A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion
Francesco Bandello et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2018)
Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes
Abdullah Ozkaya et al.
OPTOMETRY AND VISION SCIENCE (2018)
Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B)
Lars-Olof Hattenbach et al.
ACTA OPHTHALMOLOGICA (2018)
Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion
Bora Yuksel et al.
CLINICAL AND EXPERIMENTAL OPTOMETRY (2018)
A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
David G. Callanan et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015
C. Dot et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE (2015)
Retinal venous pressure: the role of endothelin
Josef Flammer et al.
EPMA JOURNAL (2015)
Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion
E. Moisseiev et al.
EYE (2013)
BRANCH RETINAL VEIN OCCLUSION Epidemiology, Pathogenesis, Risk Factors, Clinical Features, Diagnosis, and Complications. An Update of the Literature
Adil Jaulim et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Association of Inflammatory Factors With Macular Edema in Branch Retinal Vein Occlusion
Hidetaka Noma et al.
JAMA OPHTHALMOLOGY (2013)
Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
David M. Brown et al.
OPHTHALMOLOGY (2011)
Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion
Julia A. Haller et al.
OPHTHALMOLOGY (2011)
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia
Sophie Rogers et al.
OPHTHALMOLOGY (2010)
Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion
Julia A. Haller et al.
OPHTHALMOLOGY (2010)
Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6
H Noma et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection
IP Singh et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
分享论文
